Cancer Research and Treatment

CDC6 may serve as an indicator of lung adenocarcinoma prognosis and progression based on TCGA and GEO data mining and experimental analyses

Liquid biopsy for the management of NSCLC patients under osimertinib treatment

Aliki Ntzifa, Theodoros Marras, Vasilis Georgoulias, Evi Lianidou

Critical Reviews in Clinical Laboratory Sciences.2024; : 1. CrossRef

The impact of EGFR T790M mutation status following the development of Osimertinib resistance on the efficacy of Osimertinib in non‐small cell lung cancer: A meta‐analysis

Liuxian Guo, Guojin Zhou, Min Huang, Kejing Tang, Jing Xu, Jie Chen

The Clinical Respiratory Journal.2024;[Epub] CrossRef

Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC?

Yi-Ze Li, Sheng-Nan Kong, Yun-Peng Liu, Yue Yang, Hong-Mei Zhang

Journal of Clinical Medicine.2023; 12(4): 1438. CrossRef

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma

Gujie Wu, Qin Hu, Hongyu Chen, Min He, Huiyun Ma, Lin Zhou, Kun Xu, Hefei Ren, Juntao Qi

The Utility of ctDNA in Lung Cancer Clinical Research and Practice: A Systematic Review and Meta-Analysis of Clinical Studies

Xuezheng Sun, Page Abrahamson, Nicholas Ballew, Linda Kalilani, Kelesitse Phiri, Kelly F. Bell, Alexander Slowley, Magdalena Zajac, Erin Hofstatter, Alexander Stojadinovic, Angela Silvestro, Zebin Wang, Amine Aziez, Solange Peters

Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer

Liu Xin, Yang Yue, Ren Zihan, Cui Youbin, Lu Tianyu, Wang Rui

Usefulness of bronchial washing fluid for detection of EGFR mutations in non-small cell lung cancer

Woo Kyung Ryu, Seung Hyun Yong, Sang Hoon Lee, Hye Ran Gwon, Hye Ryun Kim, Min Hee Hong, Go Eun Oh, Sehee Jung, Chi Young Kim, Yoon Soo Chang, Eun Young Kim

Current treatment of non-small cells lung cancer with EGFR mutation: first-line and management upon progression

Sergio Sandiego Contreras, Lucía Morales López, Reyes Claramunt Alonso, Javier Lavernia Giner, Ignacio Gil Bazo

A novel neutrophil extracellular traps-related lncRNA signature predicts prognosis in patients with early-stage lung adenocarcinoma

Huan Wang, Yueli Shi, Xia Xu, Shumin Xu, Yuting Shi, Weiyu Chen, Kai Wang

Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer

Jiaqi Zhu, Yun Jiang, Tianyi Wang, Anqi Wu, Tingting Zhou, Anping Zhang, Yijie Tang, Zihao Shen, Jinjie Wang, Hao Zhou, Jiahai Shi, Jianle Chen, Ihtisham Bukhari

The potential of liquid biopsy in the management of cancer patients

Seminars in Cancer Biology.2022; 84: 69. CrossRef

Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges

Miguel García-Pardo, Maisam Makarem, Janice J. N. Li, Deirdre Kelly, Natasha B. Leighl

British Journal of Cancer.2022; 127(4): 592. CrossRef

Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies

Hyunkoo Kang, Haksoo Lee, Dahye Kim, Byeongsoo Kim, JiHoon Kang, Hae Yu Kim, HyeSook Youn, BuHyun Youn

Identification of molecular subtypes, risk signature, and immune landscape mediated by necroptosis-related genes in non-small cell lung cancer

Jiaqi Zhu, Jinjie Wang, Tianyi Wang, Hao Zhou, Mingming Xu, Jiliang Zha, Chen Feng, Zihao Shen, Yun Jiang, Jianle Chen

Sotorasib and other drugs comparison in treating non-small cell lung cancer

Highlights in Science, Engineering and Technology.2022; 8: 675. CrossRef

Assessment of Anti-tumor Efficacy of Osimertinib in Non-Small Cell Lung Cancer Patients by Liquid Biopsy Using Bronchoalveolar Lavage Fluid, Plasma, or Pleural Effusion

Yeon Joo Kim, Won Jun Ji, Jae-Cheol Lee, Sung-Min Chun, Chang-Min Choi

Cancer Research and Treatment.2022; 54(4): 985. CrossRef

Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer

Xiaoxu Fang, Shaokun Yu, Yingying Jiang, Yan Xiang, Kaihua Lu

Phase II open‐label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid‐Lung‐A

Cheol‐Kyu Park, Sung‐Yong Lee, Jae Cheol Lee, Chang‐Min Choi, Shin Yup Lee, Tae‐Won Jang, In‐Jae Oh, Young‐Chul Kim

A Phase II Trial of Osimertinib as the First-Line Treatment of Non–Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1

Cheol-Kyu Park, Hyun-Ju Cho, Yoo-Duk Choi, In-Jae Oh, Young-Chul Kim

Cancer Research and Treatment.2021; 53(1): 93. CrossRef

Gene signatures of 6-methyladenine regulators in women with lung adenocarcinoma and development of a risk scoring system: a retrospective study using the cancer genome atlas database

Chundi Gao, Jing Zhuang, Huayao Li, Cun Liu, Chao Zhou, Lijuan Liu, Fubin Feng, Changgang Sun

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis

Yingji Chen, Longyu Jin, Zhibin Jiang, Suo Liu, Wei Feng

PIWI‐interacting RNAs are aberrantly expressed and may serve as novel biomarkers for diagnosis of lung adenocarcinoma

Juan Li, Nan Wang, Fang Zhang, Shan Jin, Yaqi Dong, Xiangjun Dong, Yuqing Chen, Xue Kong, Yao Tong, Qi Mi, Yinghui Zhao, Yi Zhang

Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment

Hao Zhou, Miaosen Zheng, Muqi Shi, Jinjie Wang, Zhanghao Huang, Haijian Zhang, Youlang Zhou, Jiahai Shi

Molecular subtypes based on ferroptosis-related genes and tumor microenvironment infiltration characterization in lung adenocarcinoma

Weiju Zhang, Sumei Yao, Hua Huang, Hao Zhou, Haomiao Zhou, Qishuang Wei, Tingting Bian, Hui Sun, Xiaoli Li, Jianguo Zhang, Yifei Liu

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC

Bin Qiu, Wei Guo, Fan Zhang, Fang Lv, Ying Ji, Yue Peng, Xiaoxi Chen, Hua Bao, Yang Xu, Yang Shao, Fengwei Tan, Qi Xue, Shugeng Gao, Jie He

Circulating tumour DNA: A new biomarker to monitor resistance in NSCLC patients treated with EGFR-TKIs

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2020; 1873(2): 188363. CrossRef

Rescue of Non-Informative Circulating Tumor DNA to Monitor the Mutational Landscape in NSCLC

Stefanie Mayer, Gerlinde Schmidtke-Schrezenmeier, Christian Buske, Frank G. Rücker, Thomas F.E. Barth, Peter Möller, Ralf Marienfeld

Diverse fragment lengths dismiss size selection for serum cell-free DNA: a comparative study of serum and plasma samples

Yanqin Huang, Jiayi Mu, Lina Qi, Weiting Ge, Xuefeng Fang, Yongmao Song, Ying Yuan, Shu Zheng

Clinical Chemistry and Laboratory Medicine (CCLM).2020; 58(9): 1451. CrossRef

The efficacy and safety of osimertinib in treating nonsmall cell lung cancer

Jing Liu, Xuemei Li, Yinghong Shao, Xiyun Guo, Jinggui He

Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin

Ryan Woodhouse, Meijuan Li, Jason Hughes, David Delfosse, Joel Skoletsky, Pei Ma, Wei Meng, Ninad Dewal, Coren Milbury, Travis Clark, Amy Donahue, Dan Stover, Mark Kennedy, Jennifer Dacpano-Komansky, Christine Burns, Christine Vietz, Brian Alexander, Prit

Circulating tumor DNA in lung cancer: real-time monitoring of disease evolution and treatment response

Chinese Medical Journal.2020; 133(20): 2476. CrossRef

Identification of Key Genes in Lung Adenocarcinoma and Establishment of Prognostic Mode

Zhou Jiawei, Mu Min, Xing Yingru, Zhang Xin, Li Danting, Liu Yafeng, Xie Jun, Hu Wangfa, Zhang Lijun, Wu Jing, Hu Dong

Frontiers in Molecular Biosciences.2020;[Epub] CrossRef

Current Perspectives on Circulating Tumor DNA, Precision Medicine, and Personalized Clinical Management of Cancer

Kelly C.S. Oliveira, Iago Barroso Ramos, Jessica M.C. Silva, Williams Fernandes Barra, Gregory J. Riggins, Vikrant Palande, Catarina Torres Pinho, Milana Frenkel-Morgenstern, Sidney E.B. Santos, Paulo P. Assumpcao, Rommel R. Burbano, Danielle Queiroz Calc

Molecular Cancer Research.2020; 18(4): 517. CrossRef

Monitoring circulating tumor DNA by analyzing personalized cancer-specific rearrangements to detect recurrence in gastric cancer

Young-Woo Kim, Young-Ho Kim, Yura Song, Han-Seong Kim, Hye Won Sim, Shiv Poojan, Bang Wool Eom, Myeong-Cherl Kook, Jungnam Joo, Kyeong-Man Hong

Experimental & Molecular Medicine.2019; 51(8): 1. CrossRef

Osimertinib or EGFR-TKIs/chemotherapy in patients with EGFR-mutated advanced nonsmall cell lung cancer

Lei Huang, Hao Huang, Xiao-Ping Zhou, Jin-Feng Liu, Chun-Rong Li, Min Fang, Jun-Rong Wu